Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic makeup suggests. The research — which focused on human embryonic stem cells — paves the way for clinical trials of cell therapies to treat conditions such as Parkinson’s disease, age-related degeneration of the eyes and spinal cord injury.